Skip to content

Clinical trials

Terminated Carcinoma, Non-Small-Cell Lung trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Status: Terminated Country / region: Austria Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20071
20081
20092
20111
20133
20151
20171
20183
20191
20211
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated19

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Amgen2
Central European Cooperative Oncology Group2
Merck Sharp & Dohme LLC2
Pfizer2
Advanced Accelerator Applications1
CureVac1
Daiichi Sankyo1
ETOP IBCSG Partners Foundation1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung19
Carcinoma, Renal Cell2
Colorectal Neoplasms2
Neoplasm Metastasis2
Anemia1
Breast Neoplasms1
Carcinoma, Adenosquamous1
Carcinoma, Large Cell1
Carcinoma, Squamous Cell1
Head and Neck Neoplasms1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.